New Challenges in the Management of Heart Failure: Meet the Experts

Juan Carlos Kaski is Professor of Cardiovascular Science (Emeritus) at the Molecular and Clinical Sciences Research Institute, St Gorge’s, University of London, and Hon. Consultant Cardiologist at St George’s Hospital and the Royal Brompton Hospital in London, UK.  He is Doctor Honoris Causa of several universities worldwide, a past-President of the International Society of Cardiovascular Pharmacotherapy and Fellow of over 30 scientific societies worldwide. JC Kaski has received numerous national and international awards for his research work and both his clinical and educational activities. Professor Kaski is Chairman-elect, European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy, Editor-in-Chief of the European Cardiology Review Journal, Deputy Editor of the European Heart Journal, Co-Editor of the ESC Handbook on Cardiovascular Pharmacotherapy and editorial board member of JACC and over 20 other scientific journals. Prof Kaski’s research areas include inflammatory and immunological mechanisms of atherosclerosis, microvascular and vasospastic angina, INOCA and MINOCA, biomarkers of cardiovascular risk and management of angina pectoris. He has authored over 600 scientific papers on these topics in peer review journals and edited 10 books.

Professor Juan Carlos Kaski is Editor-In-Chief of the European Cardiology Review.

Giuseppe Rosano is Consultant Cardiologist and Professor of Cardiology at St George’s, University of London, UK where he is also the director of MSc Heart Failure.

Prof Rosano's areas of expertise include heart failure, cardiac metabolism, cardiovascular pharmacology and pharmacotherapy, heart disease in women and cardiovascular effects of sex hormones. He has a specific interest in chronic coronary syndromes and in angina with normal coronary arteries.

Prof Rosano has been core member of the Cardiovascular Working Party of the European Medicines Agency and member of the Pricing and Reimbursement Committee of the Italian Drug Agency. 

Prof Rosano is on the editorial board for European Journal of Heart Failure, European Heart Journal CV Pharmacotherapy, Cardiac Failure Reviews and Cardiovascular Diabetology. He has authored more than 500 peer-reviewed articles, eight books and 32 book chapters.

Dr Giuseppe Rosano is Deputy Editor-in-Chief of Cardiac Failure Review.

Dr Alexander Lyon is a leading London-based consultant cardiologist, specialising in the field of heart failure, cardiomyopathy, cardio-oncology and takotsubo syndrome. He is highly experienced, and is well-versed in all aspects of cardiology. Along with his private clinics at Royal Brompton Hospital and in central London, he is also senior lecturer for the National Heart and Lung Institute at Imperial College London.

Dr Lyon graduated with a first class degree from Oxford University, and gained experience doing post-graduate training in London and Sydney before setting up private practice in London. His clinical interests are in the field of heart failure, chemotherapy cardiomyopathy and Takotsubo cardiomyopathy, and he is the theme leader for heart failure research in the NIHR-funded Biomedical Research Unit at the Royal Brompton Hospital.

Prof Coats is Editor-in-Chief of the Cardiac Failure Review journal. He has published over 20 patents, more than 750 full research papers and more than 120,000 career citations and has a personal H-index of 146. Andrew was elected to the Presidential Trio of the Heart Failure Association of the ESC in 2018 and will serve as its president from 2020-2022.

Prof Coats is the Immediate past-President of the Heart Failure Association and past-Professor of Cardiology at the University of Warwick, UK. He has also held posts as Head of Cardiology at Imperial College, London and Associate Medical Director and Director of Cardiology at the Royal Brompton and Harefield Hospitals, London. From 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as Deputy Vice-Chancellor and Dean of Medicine at the University of Sydney.

He is an Australian-British academic cardiologist as well as a successful fundraiser, university administrator and inventor. Prof Coats' main interest is heart failure and his current position is Scientific Director at the Heart Institute, Australia.